Immunolocalization of nuclear transcription factors, DAX-1 and Ad4BP/SF-1, in human common epithelial ovarian tumors: Correlations with StAR and steroidogenic enzymes in epithelial ovarian carcinoma

International Journal of Gynecological Pathology

Volumn 24, Issue 2, 2005, Pages 153-163

  Abd Elaziz, Manar ^a   Moriya, Takuya ^a   Akahira, Jun Ichi ^a   Nakamura, Yasuhiro ^a   Suzuki, Takashi ^a   Sasano, Hironobu ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

DAX 1; Immunohistochemistry; SF 1; Steroidogenesis; Steroidogenic enzymes

Indexed keywords

MESSENGER RNA; NUCLEAR RECEPTOR DAX 1; STEROIDOGENIC ACUTE REGULATORY PROTEIN; STEROIDOGENIC FACTOR 1; TRANSCRIPTION FACTOR;

ADULT; ARTICLE; CANCER GROWTH; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; STEROID METABOLISM; STEROIDOGENESIS;

DNA-BINDING PROTEINS; ENZYMES; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; OVARIAN NEOPLASMS; PHOSPHOPROTEINS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, RETINOIC ACID; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEROIDS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 15244362098     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pgp.0000155075.75209.42     Document Type: Article

References (34)

1. Parker SL, Tong T, Bolden S, et al. Cancer statistics. CA Cancer J Clin 1997;47:5-27.
2. Rodriguez GC, Walmer DK, Cline M, et al. Effect of progestin on the ovarian epithelium of macaques: cancer prevention through apoptosis. J Soc Gynecol Investig 1998;5:271-6.
3. Clinton GM, Hua W. Estrogen action in human ovarian cancer. Crir Rev Oncol Hematol 1997;25:1-9.
4. Risch HA. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 1998;90:1774-86.
5. Emons G, Kavanagh JJ. Hormonal interactions in ovarian cancer. Hematol Oncol Clin North Am 1999;13:145-61.
6. Adami HO, Hsieh CC, Lambe M, et al. Parity, age at first childbirth and risk of ovarian cancer. Lancet 1994;344:1250-4.
7. La Vecchia C, Franceschi S. Oral contraceptives and ovarian cancer. Eur J Cancer Prev 1999;8:297-304.
8. Westhoff C, Britton JA, Gammon MD, et al. Oral contraceptive and benign ovarian tumors. Am J Epidemiol 2000;152:242-6.
9. Garg PP, Kerlikowske K, Subak L, et al. Hormonal replacement therapy and risk of epithelial ovarian carcinoma: a meta-analysis. Obstet Gynecol 1998;92:472-9.
10. Rodriguez C, Patel AV, Calle EE, et al. Estrogen replacement therapy and mortality in large prospective study of US women. JAMA 2001;285:1460-5.
11. Abrahamsson G, Janson PO, Kullander S. Steroid release from two human epithelial tumors: evidence for an intrinsic production in vitro. Gynecol Oncol 1997;64:99-104.
12. Clark BJ, Wells J, King SR, Stocco DM. The purification, cloning, and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein (StAR). J Biol Chem 1994;269:28314-22.
13. Suzuki T, Sasano H, Tamura M, et al. Temporal and spatial localization of steroidogenic enzymes in premenopausal human ovaries: in situ hybridization and immunohistochemical study. Mol Cell Endocrinol 1993;97:135-43.
14. Takayama K, Sasano H, Fukaya T, et al. Immunohistochemical localization of Ad4-binding protein with correlation to steroidogenic enzyme expression in cycling human ovaries and sex cord stromal tumors. J Clin Endocrinol Metab 1995;80:2815-21.
15. Lalli E, Melner MH, Stocco DM, et al. DAX-1 blocks steroid production at multiple levels. Endocrinology 1998;139:4237-43.
16. Reinche M, Beuschlein F, Lalli E. et al. DAX-1 expression in human adrenocortical neoplasms: implication for steroidogenesis. J Clin Endocrinol Metab 1998;83:2597-600.
17. Shibata H, Ikeda Y, Mukai T, et al. Expression profiles of COUP-TF, DAX-1 and SF-1 in the human adrenal gland and adrenocortical tumors: possible implication in steroidogenesis. Mol Genet Metab 2001;74:206-16.
18. Aylwin SJ, Welch JP, Davey CL, et al. The relation between steroidogenic factor 1 and DAX-1 expression and in vitro gonadotropin secretion in human pituitary adenoma. J Clin Endocrinol Metab 2001;86:2476-83.
19. Sato Y, Suzuki T, Hidaka K, et al. Immuno-localization of nuclear transcription factor, DAX-1 and COUP-TF II in the normal human ovary: correlation with Ad4BP/SF-1 immuno-localization during the menstrual cycle. J Clin Endocrinol Metab 2003;88: 3415-20.
20. Silverberg SG. Histological grading of ovarian carcinoma: a review and proposal. Int J Gynecol Pathol 2000;19:7-15.
21. Sasano H, Okamoto M, Mason JI, et al. Immunohistochemical studies of steroidogenic enzymes (aromatase, 17α- hydroxylases and cholesterol side-chain cleavage cytochromes P-450) in sex cord-stromal tumors of the ovary. Hum Pathol 1989;5:452-7.
22. Sasano H, Mason JI, Sasaki E, et al. Immunohistochemical study of 3β-hydroxysteroid dehydrogenase in sex cord-stromal tumors of the ovary. Int J Gynecol Pathol 1990;9:352-62.
23. McCarty KS, Miller LS, Cox EB, et al. Estrogen receptor analyses: Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med 1985; 109:716-21.
24. Suzuki T, Takahashi K, Darnel AD, et al. Chicken ovalbumin upstream promoter transcription factor II in the human adrenal cortex and its disorders. J Clin Endocrinol Metab 2000;85:2752-7.
25. Gurates B, Sebastian S, Yang S, et al. WT1 and DAX-1 inhibit Aromatase P450 expression in human endometrial and endometriotic stromal cells. J Clin Endocrinol Metab 2002;87:4369-77.
26. Abd-Elaziz M, Akahira JI, Moriya T, et al. A nuclear receptor DAX-1 in human common epithelial ovarian carcinoma: an independent prognostic factor of clinical outcome. Cancer Sci 2003;94: 980-5.
27. Lindgren PR, Backstrom T, Cajander S, et al. The pattern of estradiol and progesterone differs in serum and tissue of benign and malignant ovarian tumors. Int J Oncol 2002;21:583-9.
28. Nash DM, Hess SA, White BA, et al. Steroidogenic factor-1 regulates the rate of proliferation of normal and neoplastic rat ovarian surface epithelial cells in vitro. Endocrinology 1998;11: 4663-71.
29. Sasano H, Kaga K, Sato S, et al. Adrenal 4-binding protein in common epithelial and metastatic tumors of the ovary. Hum Pathol 1996;6:595-8.
30. Lalli E, Melner MH, Stocco DM, et al. DAX-1 blocks steroid production at multiple levels. Endocrinology 1998;139:4237-43.
31. Syed V, Ho S. Progesterone induced apoptosis in immortalized normal and malignant human ovarian surface epithelial cells involves enhanced expression of FasL. Oncogene 2003;22:6883-90.
32. Sasano H, Harada N. Intratumoral Aromatase in human breast, endometrial and ovarian malignancies. Endocr Rev 1998;19:593-607.
33. Kaga K, Sasano H, Harada N, et al. Aromatase in human common epithelial ovarian neoplasms. Am J Pathol 1996;149:45-51.
34. Ho S. Estrogen, progesterone and epithelial ovarian cancer. Reprod Biol Endocrinol 2003;1:73.